2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
复制标题

DOI:
10.1055/s-0041-1739411
复制
发表时间:
2022-01
影响因子:
6.7
通讯作者:
Lip GYH
Lip GYH
中科院分区:
医学2区
文献类型:
--
作者:
Chao TF;Joung B;Takahashi Y;Lim TW;Choi EK;Chan YH;Guo Y;Sriratanasathavorn C;Oh S;Okumura K;Lip GYH

文献摘要

参考文献

被引文献

相似文献

亚太心律学会(APHRS)于2017年发表了关于房颤(AF)卒中预防的共识,为亚太地区的心脏病学家、神经学家、老年病学家和全科医生提供了有用的临床指导。近年来,许多关于房颤卒中预防的重要新数据被报道。实践指南小组委员会成员全面审查了关于AF卒中预防的最新信息,并在2017年APHRS关于AF卒中预防的共识指南的2021年重点更新中对其进行了总结。我们强调并关注了几个问题,包括AF更好护理途径的重要性,亚洲人非维生素K拮抗剂口服抗凝剂(NOAC)的优势,对具有除性别外的单一卒中风险因素的亚洲AF患者使用NOAC的考虑因素、生活方式因素对卒中风险的作用、“2019冠状病毒病”大流行期间口服抗凝剂的使用等。我们充分认识到,当前AF知识存在差距、未解决的问题以及许多不确定性和争议领域,医生的决定仍然是房颤治疗中最重要的因素。
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The practice guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of the AF Better Care pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian AF patients with single one stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the “coronavirus disease 2019” pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.
DOI: 10.1371/journal.pone.0150674
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者:
Chan PH;Hai JJ;Chan EW;Li WH;Tse HF;Wong IC;Lip GY;Siu CW
通讯作者: Siu CW
DOI: 10.1016/j.hrthm.2016.11.025
发表时间: 2017-03-01
期刊: HEART RHYTHM
影响因子: 5.5
作者:
Boersma, Lucas V.;Barr, Craig S.;Gold, Michael R.
通讯作者: Gold, Michael R.
DOI: 10.1093/europace/eux275
发表时间: 2018-01-01
期刊: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
影响因子: --
作者:
Calkins H;Hindricks G;Cappato R;Kim YH;Saad EB;Aguinaga L;Akar JG;Badhwar V;Brugada J;Camm J;Chen PS;Chen SA;Chung MK;Nielsen JC;Curtis AB;Davies DW;Day JD;d'Avila A;de Groot NMSN;Di Biase L;Duytschaever M;Edgerton JR;Ellenbogen KA;Ellinor PT;Ernst S;Fenelon G;Gerstenfeld EP;Haines DE;Haissaguerre M;Helm RH;Hylek E;Jackman WM;Jalife J;Kalman JM;Kautzner J;Kottkamp H;Kuck KH;Kumagai K;Lee R;Lewalter T;Lindsay BD;Macle L;Mansour M;Marchlinski FE;Michaud GF;Nakagawa H;Natale A;Nattel S;Okumura K;Packer D;Pokushalov E;Reynolds MR;Sanders P;Scanavacca M;Schilling R;Tondo C;Tsao HM;Verma A;Wilber DJ;Yamane T
通讯作者: Yamane T
DOI: 10.1055/s-0038-1675400
发表时间: 2018-12
影响因子: 6.7
作者:
Borre ED;Goode A;Raitz G;Shah B;Lowenstern A;Chatterjee R;Sharan L;Allen LaPointe NM;Yapa R;Davis JK;Lallinger K;Schmidt R;Kosinski A;Al-Khatib SM;Sanders GD
通讯作者: Sanders GD
DOI: 10.1253/circj.cj-18-0222
发表时间: 2018-12-01
影响因子: 3.3
作者:
Aonuma, Kazutaka;Yamasaki, Hiro;Saito, Shigeru
通讯作者: Saito, Shigeru